‘Advanced Renal Cell Carcinoma Epidemiology Forecast - 2028' report delivers an in - depth understanding of the disease, historical & forecasted epidemiology of Advanced Renal Cell Carcinoma in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan and China.
Geography Covered
Study Period: 2017 - 2028
Advanced Renal Cell Carcinoma Epidemiology
According to the National Organization of Rare Disorders (NORD), renal cell carcinoma accounts for approximately 30,000 new cases of kidney malignancies per year in the United States. It is more common in males than in females (ratio of 2 - 3:1) and in persons with a history of smoking.
Renal cell carcinomas (RCC) are primary malignant adenocarcinomas derived from the renal tubular epithelium and are the most common malignant renal tumor. They usually occur in 50 - 70 year old patients and macroscopic hematuria occurs in 60% of the cases.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology scenario of Advanced Renal Cell Carcinoma in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017 - 2028 for the following aspects:
According to this research, the total diagnosed incident cases of Advanced Renal Cell Carcinoma in the G8 countries were 69,429 in 2017. In case of total RCC patients in the United States, the diagnosed incident cases were 53,405 in 2017.
Report Scope
Key strengths
Key assessments
Note: The publisher understands the needs of the rapidly changing market and the publisher is helping the clients by providing them with the most up to date Report. It usually takes 5 - 7 days.
Geography Covered
- The United States
- EU5 (Germany, France, Italy, Spain and the United Kingdom)
- Japan
- China
Study Period: 2017 - 2028
Advanced Renal Cell Carcinoma Epidemiology
According to the National Organization of Rare Disorders (NORD), renal cell carcinoma accounts for approximately 30,000 new cases of kidney malignancies per year in the United States. It is more common in males than in females (ratio of 2 - 3:1) and in persons with a history of smoking.
Renal cell carcinomas (RCC) are primary malignant adenocarcinomas derived from the renal tubular epithelium and are the most common malignant renal tumor. They usually occur in 50 - 70 year old patients and macroscopic hematuria occurs in 60% of the cases.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology scenario of Advanced Renal Cell Carcinoma in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017 - 2028 for the following aspects:
- Diagnosed Incident Cases of Renal Cell Carcinoma (RCC)
- Gender - specific Diagnosed Incidence of Renal Cell Carcinoma (RCC)
- Subtype - specific Diagnosed Incidence of Renal Cell Carcinoma (RCC)
- Stage - specific Diagnosed Incident Cases of RCC
- Total Cases of Advanced/Metastatic RCC
According to this research, the total diagnosed incident cases of Advanced Renal Cell Carcinoma in the G8 countries were 69,429 in 2017. In case of total RCC patients in the United States, the diagnosed incident cases were 53,405 in 2017.
Report Scope
- The report covers the detailed overview of Advanced Renal Cell Carcinoma explaining its causes, symptoms, and classification, pathophysiology, diagnosis and treatment patterns.
- The report provides insight about the historical and forecasted patient pool for G8 countries covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan and China.
- The report assesses the disease risk and burden and highlights the unmet needs of Advanced Renal Cell Carcinoma.
- The report helps to recognize the growth opportunities in the G8 countries with respect to the patient population.
- The report provides the segmentation of the disease epidemiology by type - specific cases and severity specific cases of Advanced Renal Cell Carcinoma in the G8 countries.
Key strengths
- 10 - Year Forecast of Advanced Renal Cell Carcinoma epidemiology
- G8 countries Coverage
- Total Incident Cases of Advanced Renal Cell Carcinoma
- Incident Cases according to segmentation
Key assessments
- Patient Segmentation
- Disease Risk and Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
Note: The publisher understands the needs of the rapidly changing market and the publisher is helping the clients by providing them with the most up to date Report. It usually takes 5 - 7 days.
Note: Product cover images may vary from those shown
1. Key Insights6. Publisher Capabilities7. Disclaimer8. About the Publisher
2. Disease Background and Overview: Advanced Renal Cell carcinoma
3. Epidemiology and Patient Population
4. Country Wise-Epidemiology of Advanced Renal Cell Carcinoma (RCC)
5. Appendix
Note: Product cover images may vary from those shown
